Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma
Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl carboxylase in HCC cells, the 10 glutamic acid (Glu) residues in prothrombin precursor did not completely carboxylate to γ-carboxylated glutamic aci...
Saved in:
Published in | Cellular physiology and biochemistry Vol. 34; no. 3; pp. 903 - 915 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Basel, Switzerland
Cell Physiol Biochem Press GmbH & Co KG
01.01.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl carboxylase in HCC cells, the 10 glutamic acid (Glu) residues in prothrombin precursor did not completely carboxylate to γ-carboxylated glutamic acid (Gla) residues, leaving some Glu residues remained in N-terminal domain. These prothrombin precursors with Glu residues are called DCPs. DCP displays insufficient coagulation activity. Since Liebman reported an elevated plasma DCP in patients with HCC, DCP has been used in the diagnosis of HCC. Recently, its biological malignant potential has been specified to describe DCP as an autologous growth factor to stimulate HCC growth and a paracrine factor to integrate HCC with vascular endothelial cells. DCP was found to stimulate HCC growth through activation of the DCP-Met-JAK1-STAT3 signaling pathway. DCP might increase HCC invasion and metastasis through activation of matrix metalloproteinase (MMPs) and the ERK1/2 MAPK signaling pathway. DCP has also been found to play a crucial role in the formation of angiogenesis. DCP could increase the angiogenic factors released from HCC and vascular endothelial cells. These effects of DCP in angiogenesis might be related to activation of the DCP-KDR-PLC-γ-MAPK signaling pathway. In this article, we summarized recent studies on DCP in biological roles related to cancer progression and angiogenesis in HCC. |
---|---|
AbstractList | Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl carboxylase in HCC cells, the 10 glutamic acid (Glu) residues in prothrombin precursor did not completely carboxylate to γ-carboxylated glutamic acid (Gla) residues, leaving some Glu residues remained in N-terminal domain. These prothrombin precursors with Glu residues are called DCPs. DCP displays insufficient coagulation activity. Since Liebman reported an elevated plasma DCP in patients with HCC, DCP has been used in the diagnosis of HCC. Recently, its biological malignant potential has been specified to describe DCP as an autologous growth factor to stimulate HCC growth and a paracrine factor to integrate HCC with vascular endothelial cells. DCP was found to stimulate HCC growth through activation of the DCP-Met-JAK1-STAT3 signaling pathway. DCP might increase HCC invasion and metastasis through activation of matrix metalloproteinase (MMPs) and the ERK1/2 MAPK signaling pathway. DCP has also been found to play a crucial role in the formation of angiogenesis. DCP could increase the angiogenic factors released from HCC and vascular endothelial cells. These effects of DCP in angiogenesis might be related to activation of the DCP-KDR-PLC-γ-MAPK signaling pathway. In this article, we summarized recent studies on DCP in biological roles related to cancer progression and angiogenesis in HCC. |
Author | Chu, Jia-Hui Qu, Xian-Jun Song, Zhi-Yu Zhang, Yu-Sheng Cui, Shu-Xiang |
Author_xml | – sequence: 1 givenname: Yu-Sheng surname: Zhang fullname: Zhang, Yu-Sheng – sequence: 2 givenname: Jia-Hui surname: Chu fullname: Chu, Jia-Hui – sequence: 3 givenname: Shu-Xiang surname: Cui fullname: Cui, Shu-Xiang – sequence: 4 givenname: Zhi-Yu surname: Song fullname: Song, Zhi-Yu – sequence: 5 givenname: Xian-Jun surname: Qu fullname: Qu, Xian-Jun email: qxj@sdu.edu.cn or quxj@ccmu.edu.cn |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25200250$$D View this record in MEDLINE/PubMed |
BookMark | eNptkctu1DAUhi1URC-wYI-QJTbtImA7cWIvS4ZepErMAtbWiePMpCQ5g-1A-1y8B8-ES4ZZsbBsH336ftn_KTmacHKEvObsPedSf2CM5WWZM_WMnPBC8ExXlTpKZ8ZlprSqjslpCPcsXSstXpBjIQVjQrIT8rByIfv9K6vBN_jwSNce49bj2PQTPV_V6wsKgQJdY3RT7GGgl3PEATc4B3rt8Wfc0iuwET3t0opbR1fuhxtwNyaeYkdv3A4iWjcM8wCephzbTzjCS_K8gyG4V_v9jHy9-vSlvsnuPl_f1pd3mS0Yi5nIOeSd5k3DywKkBGd5pTUvVKsktEIo1nIouNDAbRqAZmXbOFtVoMqmbfMzcrt4W4R7s_P9CP7RIPTm7wD9xoCPvR2cYYXLpUgeBaooXKdtpaVVHLROkwqS63xx7Tx-n12IZuzD09NgculDDJephJJJzRJ6saDWYwjedYdozsxTaeZQWmLf7rVzM7r2QP5rKQHvFuAb-I3zB6Bef1wUZtd2iXrzX2qf8gfm2qhj |
CitedBy_id | crossref_primary_10_1016_j_prp_2024_155216 crossref_primary_10_3892_ijo_2020_5035 crossref_primary_10_1080_07357907_2016_1227445 crossref_primary_10_3748_wjg_v30_i17_2343 crossref_primary_10_1007_s10238_018_0528_z crossref_primary_10_18632_oncotarget_9168 crossref_primary_10_1097_JS9_0000000000000376 crossref_primary_10_3233_THC_231470 crossref_primary_10_1007_s11901_023_00626_3 crossref_primary_10_3389_fonc_2021_726213 crossref_primary_10_1111_hepr_13750 crossref_primary_10_21164_pomjlifesci_477 crossref_primary_10_1155_2018_3120185 crossref_primary_10_1177_1724600818760234 crossref_primary_10_1186_s40001_023_01310_4 crossref_primary_10_24293_ijcpml_v26i2_1436 crossref_primary_10_3390_cancers14061493 crossref_primary_10_3390_cancers16050901 crossref_primary_10_1002_jgh3_12879 crossref_primary_10_1016_j_ejrad_2024_111551 crossref_primary_10_2174_1568009621999210120182834 crossref_primary_10_1371_journal_pone_0265235 crossref_primary_10_3389_fpubh_2021_784718 crossref_primary_10_7717_peerj_15988 crossref_primary_10_1007_s12328_021_01567_4 crossref_primary_10_1186_s43556_024_00184_0 crossref_primary_10_3390_biom13091369 crossref_primary_10_3748_wjg_v25_i36_5515 crossref_primary_10_1111_1440_1681_13745 crossref_primary_10_1038_s41598_024_59174_5 crossref_primary_10_3389_fcell_2020_00055 |
ContentType | Journal Article |
Copyright | 2014 S. Karger AG, Basel 2014 S. Karger AG, Basel. |
Copyright_xml | – notice: 2014 S. Karger AG, Basel – notice: 2014 S. Karger AG, Basel. |
DBID | M-- CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 DOA |
DOI | 10.1159/000366308 |
DatabaseName | Karger Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: M-- name: Karger Open Access url: https://www.karger.com/OpenAccess sourceTypes: Enrichment Source Publisher |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1421-9778 |
EndPage | 915 |
ExternalDocumentID | oai_doaj_org_article_04e352a1c8a844ef9c795c81a998a87a 10_1159_000366308 25200250 366308 |
Genre | Research Support, Non-U.S. Gov't Journal Article Review |
GroupedDBID | --- 0R~ 0~B 29B 30W 326 36B 3O. 4.4 53G 5GY 5VS 6J9 8UI AAFWJ AAYIC ACGFO ACGFS ADBBV AENEX AEYAO AFPKN AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV CS3 CYUIP DIK DU5 E0A E3Z EBS EJD EMB EMOBN F5P FB. GROUPED_DOAJ HZ~ IPNFZ KQ8 KUZGX M-- ML- N9A O1H O9- OK1 P2P RIG RKO RNS SV3 UJ6 3V. 7X7 88E 8FI 8FJ ABUWG ADAGL AFKRA AIOBO BENPR BPHCQ BVXVI CAG CCPQU CGR COF CUY CVF ECM EIF FYUFA HMCUK IAO IHR ITC M1P NPM PQQKQ PROAC PSQYO RXVBD UKHRP AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c400t-231a3f91bb164a55aec1799148d85ad2280d1a4129a1c5ada906dbec77a86bdd3 |
IEDL.DBID | DOA |
ISSN | 1015-8987 |
IngestDate | Thu Jul 04 20:55:53 EDT 2024 Fri Jun 28 10:42:33 EDT 2024 Thu Sep 26 16:46:56 EDT 2024 Sat Sep 28 08:38:50 EDT 2024 Thu Sep 05 17:59:13 EDT 2024 Thu Aug 29 12:04:42 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Signaling pathways Angiogenesis Autologous growth factor Hepatocellular carcinoma (HCC) Des-γ-carboxy prothrombin (DCP) Stimulation Paracrine factor |
Language | English |
License | Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) applicable to the online version of the article only. Distribution permitted for non-commercial purposes only. 2014 S. Karger AG, Basel. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c400t-231a3f91bb164a55aec1799148d85ad2280d1a4129a1c5ada906dbec77a86bdd3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
OpenAccessLink | https://doaj.org/article/04e352a1c8a844ef9c795c81a998a87a |
PMID | 25200250 |
PQID | 1563060590 |
PQPubID | 23479 |
PageCount | 13 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_04e352a1c8a844ef9c795c81a998a87a karger_primary_366308 pubmed_primary_25200250 proquest_miscellaneous_1563060590 crossref_primary_10_1159_000366308 |
PublicationCentury | 2000 |
PublicationDate | 2014-01-01 |
PublicationDateYYYYMMDD | 2014-01-01 |
PublicationDate_xml | – month: 01 year: 2014 text: 2014-01-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | Basel, Switzerland |
PublicationPlace_xml | – name: Basel, Switzerland – name: Germany |
PublicationTitle | Cellular physiology and biochemistry |
PublicationTitleAlternate | Cell Physiol Biochem |
PublicationYear | 2014 |
Publisher | Cell Physiol Biochem Press GmbH & Co KG |
Publisher_xml | – name: Cell Physiol Biochem Press GmbH & Co KG |
References | Liebman HA, Furie BC, Tong MJ, Blanchard RA, Lo KJ, Lee SD, Coleman MS, Furie B: Des-gamma-carboxy (abnormal) prothrombin as a serum marker of primary hepatocellular carcinoma. N Engl J Med 1984;310:1427-1431.620174110.1056/NEJM198405313102204 Gao J, Feng X, Inagaki Y, Song P, Kokudo N, Hasegawa K, Sugawara Y, Tang W: Des-γ-carboxy prothrombin and c-Met were concurrently and extensively expressed in hepatocellular carcinoma and associated with tumor recurrence. Biosci Trends 2012;6:153-159.2300696110.5582/bst.2012.v6.4.153 Saito M, Seo Y, Yano Y, Miki A, Yoshida M, Azuma T: A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment. J Gastroenterol 2012;47:1134-1142.2244153310.1007/s00535-012-0577-0 Weitz IC, Liebman HA: Des-gamma-carboxy (abnormal) prothrombin and hepatocellular carcinoma: a critical review. Hepatology 1993;18:990-997.840637410.1002/hep.1840180434 Bertino G, Ardiri AM, Boemi PM, Ierna D, Interlandi D, Caruso L, Minona E, Trovato MA, Vicari S, Li Destri G, Puleo S: A study about mechanisms of des-gamma-carboxy prothrombin‘s production in hepatocellular carcinoma. Panminerva Med 2008;50:221-226.18927526 Ueda N, Shiraha H, Fujikawa T, Takaoka N, Nakanishi Y, Suzuki M, Matsuo N, Tanaka S, Nishina S, Uemura M, Takaki A, Shiratori Y, Yamamoto K: Exon 2 deletion splice variant of gamma-glutamyl carboxylase causes des-gamma-carboxy prothrombin production in hepatocellular carcinoma cell lines. Mol Oncol 2008;2:241-249.1938334510.1016/j.molonc.2008.06.004 Murata K, Sakamoto A: Impairment of clathrin-mediated endocytosis via cytoskeletal change by epithelial to fibroblastoid conversion in HepG2 cells: a possible mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma. Int J Oncol 2008;33:1149-1155.1902074710.3892/ijo_00000104 Inagaki Y, Qi F, Gao J, Qu X, Hasegawa K, Sugawara Y, Tang W, Kokudo N: Effect of c-Met inhibitor SU11274 on hepatocellular carcinoma cell growth. Biosci Trends 2011;5:52-56.2157224710.5582/bst.2011.v5.2.52 Wang SB, Cheng YN, Cui SX, Zhong JL, Ward SG, Sun LR, Chen MH, Kokudo N, Tang W, Qu XJ: Des-gamma-carboxy prothrombin stimulates human vascular endothelial cell growth and migration. Clin Exp Metastasis 2009;26:469-477.1926322910.1007/s10585-009-9246-y Zhao D, Zhai B, He C, Tan G, Jiang X, Pan S, Dong X, Wei Z, Ma L, Qiao H, Jiang H, Sun X: Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells. Cell Signal 2014;26:1030-1039.2448641210.1016/j.cellsig.2014.01.026 Basilico C, Arnesano A, Galluzzo M, Comoglio PM, Michieli P: A high affinity hepatocyte growth factor-binding site in the immunoglobulin-like region of Met. J Biol Chem 2008;283:21267-21277.1849566310.1074/jbc.M800727200 Yamaguchi R, Yano H, Nakashima Y, Ogasawara S, Higaki K, Akiba J, Hicklin DJ, Kojiro M: Expression and localization of vascular endothelial growth factor receptors in human hepatocellular carcinoma and non-HCC tissues. Oncol Rep 2000;7:725-729.1085453310.3892/or.7.4.725 Yamashita Y, Tsuijita E, Takeishi K, Fujiwara M, Kira S, Mori M, Aishima S, Taketomi A, Shirabe K, Ishida T, Maehara Y: Predictors for microinvasion of small hepatocellular carcinoma ≤ 2 cm. Ann Surg Oncol 2012;19:2027-2034.2220318410.1245/s10434-011-2195-0 Yamagata H, Nakanishi T, Furukawa M, Okuda H, Obata H: Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue. J Gastroenterol Hepatol 1995;10:8-13.762011310.1111/j.1440-1746.1995.tb01040.x Miyakawa T, Kajiwara Y, Shirahata A, Okamoto K, Itoh H, Ohsato K: Vitamin K contents in liver tissue of hepatocellular carcinoma patients. Jpn J Cancer Res 2000;91:68-74.1074404610.1111/j.1349-7006.2000.tb00861.x Sekiya C, Kohda H, Hasebe C, Namiki M, Watanabe K, Naraki T: Characteristics of the PIVKA-II found in hepatocellular carcinoma: Investigation using monoclonal antibodies MU-3 and 19B7. Int Hepatol Commun 1994;2:277-284.10.1016/0928-4346(94)90063-9 Sorciano-Garcia M, Padmanabhan K, de Vos AM, Tullunsky A: The Ca2+ ion and membrane binding structure of the Gla domain of Ca-prothrombin fragment 1. Biochemistry 1992;31:2554-2566.154723810.1021/bi00124a016 Guo RP, Zhong C, Shi M, Zhang CQ, Wei W, Zhang YQ, Li JQ: Clinical value of apoptosis and angiogenesis factors in estimating the prognosis of hepatocellular carcinoma. J Cancer Res Clin Oncol 2006;132:547-555.1676380510.1007/s00432-006-0097-5 Suzuki H, Murata K, Gotoh T, Kusano M, Okano H, Oyamada T, Yasuda Y, Imamura M, Kudo M, Mizokami M, Sakamoto A: Phenotype-dependent production of des-γ-carboxy prothrombin in hepatocellular carcinoma. J Gastroenterol 2011;46:1219-1229.2174412910.1007/s00535-011-0432-8 Nagaoka S, Yatsuhashi H, Hamada H, Yano K, Matsumoto T, Daikoku M, Arisawa K, Ishibashi H, Koga M, Sata M, Yano M: The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. Cancer 2003;98:2671-2677.1466928810.1002/cncr.11839 Naraki T, Kohno N, Saito H, Fujimoto Y, Ohhira M, Morita T, Kohgo Y: gamma-Carboxyglutamic acid content of hepatocellular carcinoma-associated des-gamma-carboxy prothrombin. Biochim Biophys Acta 2002;1586:287-298.1199708010.1016/S0925-4439(01)00107-7 Yue P, Gao ZH, Xue X, Cui SX, Zhao CR, Yuan Y, Yin Z, Inagaki Y, Kokudo N, Tang W, Qu XJ: Des-γ-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathway. Eur J Cancer 2011;47:1115-1124.2134970110.1016/j.ejca.2011.01.017 Otsuka M, Kato N, Shao RX, Hoshida Y, Ijichi H, Koike Y, Taniguchi H, Moriyama M, Shiratori Y, Kawabe T, Omata M: Vitamin K2 inhibits the growth and invasiveness of hepatocellular carcinoma cells via protein kinase A activation. Hepatology 2004;40:243-251.1523910810.1002/hep.20260 Hu B, Tian X, Sun J, Meng X: Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis. Int J Mol Sci 2013;14:23559-23580.2431743110.3390/ijms141223559 Gao FJ, Cui SX, Chen MH, Cheng YN, Sun LR, Ward SG, Kokudo N, Tang W, Qu XJ: Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sci 2008;83:815-820.1897667410.1016/j.lfs.2008.10.003 Morimoto Y, Nouso K, Wada N, Takeuchi Y, Kinugasa H, Miyahara K, Yasunaka T, Kuwaki K, Onishi H, Ikeda F, Miyake Y, Nakamura S, Shiraha H, Takaki A, Yamamoto K: Involvement of platelets in extra-hepatic metastasis of hepatocellular carcinoma. Hepatol Res 2014; doi: 10.1111/hepr.12315.2455235010.1111/hepr.12315 Fujikawa T, Shiraha H, Ueda N, Takaoka N, Nakanishi Y, Matsuo N, Tanaka A, Sakaguchi K, Shiraton Y: Des-gamma-carboxyl prothrombin-promoted vascular endothelial cell proliferation and migration. J Biol Chem 2007;282:8741-8748.1725510210.1074/jbc.M609358200 Sugimoto H, Takeda S, Inoue S, Kaneko T, Watanabe K, Nakao A: Des-gamma-carboxy prothrombin (DCP) ratio, a novel parameter measured by monoclonal antibodies MU-3 and 19B7, as a new prognostic indicator for hepatocellular carcinoma. Liver Int 2003;23:38-44.1264072610.1034/j.1600-0676.2003.01777.x Muto J, Shirabe K, Sugimachi K, Maehara Y: A review of angiogenesis in hepatocellular carcinoma. Hepatol Res 2014; doi: 10.1111/hepr.12310.2453348710.1111/hepr.12310 Ohhira M, Ohtake T, Saito H, Ikuta K, Tanaka K, Tanabe H, Kawashima T, Fujimoto Y, Naraki T, Ono M, Kohgo Y: Increase of serum des-gamma-carboxy prothrombin in alcoholic liver disease without hepatocellular carcinoma. Alcohol Clin Exp Res 1999;23:67S-70S.1023528210.1111/j.1530-0277.1999.tb04537.x Murata K, Suzuki H, Okano H, Oyamada T, Yasuda Y, Sakamoto A: Cytoskeletal changes during epithelial-to-fibroblastoid conversion as a crucial mechanism of des-gamma-carboxy prothrombin production in hepatocellular carcinoma. Int J Oncol 2009;35:1005-1014.1978725410.3892/ijo_00000415 Furie B, Furie BC: Molecular basis of vitamin K-dependent gamma-carboxylation. Blood 1990;75:1753-1762.2184900 Marrero JA, Su GL, Emick D, Conjeevaram HS, Fontana RJ, Lok AS: Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 2003;37:1114-1121.1271739210.1053/jhep.2003.50195 Zhang Q, Bai X, Chen W, Ma T, Hu Q, Liang C, Xie S, Chen C, Hu L, Xu S, Liang T: Wnt/β-catenin signaling enhances hypoxia-induced epithelial-mesenchymal transition in hepatocellular carcinoma via crosstalk with hif-1α signaling. Carcinogenesis 2013;34:962-973.2335885210.1093/carcin/bgt027 Bertino G, Ardiri A, Malaguarnera M, Malaguarnera G, Bertino N, Calvagno GS: Hepatocellualar carcinoma serum markers. Semin Oncol 2012;39:410-433.2284685910.1053/j.seminoncol.2012.05.001 Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, Koike K, Takaki A, Shiratori Y: Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 2005;280:6409-6415.1558299510.1074/jbc.M406714200 Ratcliffe JV, Furie B, Furie BC: The importance of specific γ-carboxyglutamic acid residues in prothrombin. J Biol Chem 1993;268:24339-24345.8226983 Matsubara M, Shiraha H, Kataoka J, Iwamuro M, Horiguchi S, Nishina S, Takaoka N, Uemura M, Takaki A, Nakamura S, Kobayashi Y, Nouso K, Yamamoto K: Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma. J Gastroenterol Hepatol 2012;27:1602-1608.2255429210.1111/j.1440-1746.2012.07173.x Tanaka T, Taniguchi T, Sannomiya K, Takenaka H, Tomonari T, Okamoto K, Kitamura S, Okahisa T, Tamaki K, Mikasa H, Suzuki S, Takayama T: Novel des-γ-carboxy prothrombin in serum for the diagnosis of hepatocellular carcinoma. J Gastroenterol Hepatol 2013;28:1348-1355.2343234510.1111/jgh.12166 Uehara S, Gotoh K, Handa H, Honjo K, Hirayama A: Process of carboxylation of glutamic acid resid |
References_xml | |
SSID | ssj0015792 |
Score | 2.3218973 |
SecondaryResourceType | review_article |
Snippet | Des-γ-carboxy prothrombin (DCP) is a prothrombin precursor produced in hepatocellular carcinoma (HCC). Because of deficiency of vitamin K or γ-glutamyl... |
SourceID | doaj proquest crossref pubmed karger |
SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 903 |
SubjectTerms | Angiogenesis Autologous growth factor Biomarkers - chemistry Biomarkers, Tumor Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - physiopathology Des-γ-carboxy prothrombin (DCP) Growth Substances - physiology Hepatocellular carcinoma (HCC) Humans Liver Neoplasms - diagnosis Liver Neoplasms - physiopathology Molecular Structure Paracrine factor Protein Precursors - chemistry Protein Precursors - physiology Prothrombin - chemistry Prothrombin - physiology Review Signaling pathways Stimulation |
SummonAdditionalLinks | – databaseName: Karger Open Access dbid: M-- link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwELWqogouiH4AgRYZxAEOFpusHSfHNmW7qgTaQyv1Fo1jm0qoSbWkUvu7-j_4TczYSdQi9RgncSKPrXlvPH7D2OfUZsZ5lQkjlRZSey1KA3iZ4WyZW69UQ3HIHz_z5bk8vVAXQ7yDzsL8pvznII06aQugw_0WdFPyOZ3qfZZphNyUpCfEtF-gdBn3NVMlCqTRg4bQo1dJ95dEhjI6Y__ACQWtfnRA8dNPI83gcRav2MsBKvLDaNtttuHaHbYVi0fe7bDn1VirbZfdIn0Uf-9FBWvT3d7x1bqj-gdXSHv5l-Nq9ZXDHw581fWUHESd3oS6tUj7-QkS8f6SL0LhHY4YliMm5A-SiXjn-RK9Vt9RlJ_SVnlFFYja7gr22Pni-1m1FENNBdHgau0FwjmY-zI1BnkSKAWuIU04JEW2UGBJHMemIBEFQNpgA5Sz3KKdtYYiN9bOX7PNtmvdW8Z1k8scAaeV2Uw2BrGcsak3vkBWPVPWJezTOMj1dZTOqAPlUGU9GSVhRzT80wOkdh0auvWvelg89Uw6xIn4QwUUUjpfNrpUTZECckUoNCRsLxpv6mbsfP-_9mp1FG_V19Yn7ONo6hrtRWMIrcORr1NSTcvpXG7C3sQ5MHUxzqF3T3z0PXuBoErGMM0-2-zXN-4AgUtvPoQ5-w9TdeSy priority: 102 providerName: Karger AG |
Title | Des-γ-Carboxy Prothrombin (DCP) as a Potential Autologous Growth Factor for the Development of Hepatocellular Carcinoma |
URI | https://karger.com/doi/10.1159/000366308 https://www.ncbi.nlm.nih.gov/pubmed/25200250 https://search.proquest.com/docview/1563060590 https://doaj.org/article/04e352a1c8a844ef9c795c81a998a87a |
Volume | 34 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUlENJLaT7auvlALT20B5GVV7LsY-J0uxRS9tBAbmZkSRRK7LBxIPld-R_5TZmx7GUJlFx6WVitEWZmzLwnz77H2BfpUuuDToVV2ghlghGFBfyaYrVMXdC6pnPI81_Z_EL9vNSXa1ZfNBMW5YFj4I4nyiNGAFnnkCvlQ1GbQte5BOQJkJsIjaQeydTw_kCbIr7nlFrkSKsHTSHs3ce9BEs2JT_JtU7UC_ZjF_pL89fLf8PNvu3M3rI3A17kJ_E-t9kr3-ywzeggeb_DtsrRsG2X3SGHFI8PooSlbe_u-WLZkgnCFXJf_vWsXHzjcMOBL9qOJoRo09vevBa5P_-BbLz7w2e9-w5HIMsRGPK1iSLeBj7H1tW1dNRPs6u8JBuipr2CPXYx-_67nIvBWEHU-Mh2AjEdTEMhrUWyBFqDr0kYDpmRyzU4UshxEhRCAYw7LkAxyRwm2xjIM-vc9B3baNrGf2Dc1JnKEHU6lU5UbRHQWSeDDTlS64l2PmGfxyBX11E_o-p5hy6qVSYSdkrhX11Aktf9AhZCNRRC9VIhJGwvJm-1zbj5wbP1cnEaf6quXUjYpzHVFeaLYgiNx8hXkqTTMvpzbsLexxpYbZGSWhWix4__48732WuEYSoe7BywjW556w8R6nT2qK9q_DwX4glxx_lZ |
link.rule.ids | 315,786,790,870,2115,27666,27955,27956 |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Des-%CE%B3-carboxy+prothrombin+%28DCP%29+as+a+potential+autologous+growth+factor+for+the+development+of+hepatocellular+carcinoma&rft.jtitle=Cellular+physiology+and+biochemistry&rft.au=Zhang%2C+Yu-Sheng&rft.au=Chu%2C+Jia-Hui&rft.au=Cui%2C+Shu-Xiang&rft.au=Song%2C+Zhi-Yu&rft.date=2014-01-01&rft.eissn=1421-9778&rft.volume=34&rft.issue=3&rft.spage=903&rft_id=info:doi/10.1159%2F000366308&rft_id=info%3Apmid%2F25200250&rft.externalDocID=25200250 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1015-8987&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1015-8987&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1015-8987&client=summon |